The Christie NHS Foundation Trust rated as Outstanding for second time by Care Quality Commission

England’s Chief Inspector of Hospitals has found the quality of care provided by The Christie NHS Foundation Trust to be Outstanding after an inspection by the CQC.

CQC inspectors visited the trust to conduct a comprehensive inspection of its services, in July this year. Inspectors also reviewed the management and leadership of the trust to answer the question: Is the trust well-led?

The trust had previously been rated Outstanding in May 2016.  At this inspection the trust maintained its overall rating of Outstanding. It also sustained its previous rating of Outstanding for being effective, caring, responsive and well-led and Good for being safe.

The Chief Inspector of Hospitals, Professor Ted Baker, said:

“We reported in 2016 that The Christie was of exceptional quality and a leader in its field, helping to shape the future of cancer care. This passion for high quality care and innovative practice has continued, and we have found them to be Outstanding for a second time. 

“Our inspectors again heard and saw great examples of patient care which were delivered by exceptionally caring staff. People told us that they felt like partners in their care planning and staff were extremely responsive to their changing needs.

“When we inspected whether the trust was well-led, we found that the leadership was able to demonstrate that they had expertise and were committed to and capable of delivering high quality sustainable care. There was a clear focus on constructive engagement throughout the trust, inviting challenge to drive improvements in the service. This led to high levels of satisfaction by patients, staff, and stakeholders.

“A second Outstanding rating is a well-deserved achievement. Everyone at the trust should be very proud.”

The full report, including ratings, is available at:   

The trust had expanded its chemotherapy service to include an additional 10 local sites and a mobile unit capable of treating patients at their own homes. Patients had a variety of methods and opportunity to access treatment. Work was underway to reduce the time it takes for a patient to be treated, after referral.  

The trust had also consolidated some of its services into one unit, allowing patients access to a broader scope of treatments quickly, without the need for interdepartmental transfers and overnight stays. A new resource called Enhanced Supportive Care was available to patients to help them cope with the physical and mental strain that cancer causes.

Inspectors found that the trust continues to focus on innovative technology. The UK’s first high energy proton beam therapy centre is due to be opened at The Christie. Multidisciplinary surgical teams at the trust had developed new treatments to tackle rare abdominal cancers. Some patients who had previously been told that there was no treatment available, showed positive outcomes and an improved quality of life. The trust has also doubled the number of patients that could access the latest and least invasive cancer surgery.